SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000812796-05-000013
Filing Date
2005-05-04
Accepted
2005-05-04 15:25:40
Documents
2
Period of Report
2005-05-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 TJ MADISON DIRECTOR madison.htm 8-K 22345
2 TJ MADISON PRESS RELEASE pressreleasetjmadison.htm EX-99.1 16918
  Complete submission text file 0000812796-05-000013.txt   41040
Mailing Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139
Business Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139 305-534-3383
DOR BIOPHARMA INC (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16929 | Film No.: 05798843
SIC: 2834 Pharmaceutical Preparations